Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.110.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.342SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.500SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.511SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.428.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.506SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.482SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.335SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.499.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.116SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.134SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.393SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.381SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.32SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.516SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.526SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.279SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AE.7SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.51SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.18SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XATSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.11SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.85SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.65SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BG.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.61SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.1.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.74SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BM.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.62SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.2.13.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BF.28SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.1.1.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
XAZSYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BE.4SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.1.16SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.26SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used